umbilical cord derived MSCs
/ Cell Energy Life Sciences Group
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 18, 2025
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
(clinicaltrials.gov)
- P1/2 | N=150 | Recruiting | Sponsor: Cell Energy Life Sciences Group Co. LTD | Trial completion date: Jul 2026 ➔ Jul 2028 | Trial primary completion date: Jul 2025 ➔ Jul 2027
Trial completion date • Trial primary completion date • Human Immunodeficiency Virus • Infectious Disease • CD4
December 11, 2023
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
(clinicaltrials.gov)
- P1/2 | N=120 | Recruiting | Sponsor: Cell Energy Life Sciences Group Co. LTD | Not yet recruiting ➔ Recruiting
Enrollment open • Human Immunodeficiency Virus • Infectious Disease • CD4
July 12, 2023
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
(clinicaltrials.gov)
- P1/2 | N=120 | Not yet recruiting | Sponsor: Cell Energy Life Sciences Group Co. LTD
New P1/2 trial • Human Immunodeficiency Virus • Infectious Disease • CD4
1 to 3
Of
3
Go to page
1